The Science
The natural fallacy: what your body actually does with α-MSH
The most repeated justification in the Melanotan II market is one sentence long: it’s natural — your body already makes this hormone.
It appears in forum guides, on wellness-clinic menus, and in the caption economy around the sprays. The logic sounds clean. The body makes a hormone; the vial contains that hormone; therefore the vial is merely supplementing something the body already does. The TGA, Australia’s medicines regulator, has read this argument enough times to answer it in writing: “Promoters of these tanning products often claim they are safe and natural. They are far from safe.”
The regulator’s rebuttal stops at safety. The deeper problem is the word itself. “Natural” is doing pharmacological work it was never entitled to. What the body actually does with its own melanocortin hormone is the opposite of what the vial does — and the difference is not a detail. It is the entire design.
Your body’s version is a whisper, by design
The natural hormone is α-MSH — alpha-melanocyte-stimulating hormone, thirteen amino acids cleaved from a larger precursor protein. The body makes it locally, where it is needed. When ultraviolet light lands on the skin, the cells of the epidermis manufacture their own α-MSH right there, and it acts on the pigment cells next door. That is how a suntan is built (the tan without the sun): a local signal, released in response to a local event.
The other thing the body does with α-MSH is destroy it. Plasma enzymes chew the hormone up within minutes of release. That measured half-life is short — on the order of ten minutes — and it is not a flaw. It is the control system. Melanocortin signalling runs several unrelated jobs: pigment in the skin, hunger and arousal in the brain, secretions in the glands. The body keeps those jobs from bleeding into one another by keeping each signal brief, local, and quickly erased. A messenger that vanishes in minutes can say one thing, in one place, and then be gone.
That is what “natural” melanocortin signalling actually looks like: whispered, addressable, disposable.
The vial is an analog, and the edits were deliberate
Melanotan II is not α-MSH. It is an engineered analog of it, and every edit exists to defeat exactly the controls described above.
Three substitutions make the molecule resistant to the enzymes that erase the natural hormone in minutes: a norleucine at position 4 that can’t be oxidised, a mirror-image D-amino acid at position 7 that ordinary proteases can’t cut, and a cyclic ring clamping the whole structure into a shape that hides its remaining weak points. The result persists in the circulation several-fold longer than the signal it imitates.
Read that again, because it inverts the sales pitch. The molecule was not kept natural. It was deliberately edited away from nature — away from the fragility that lets the body use this signal safely. The durability is the point of the chemistry, and the durability is what makes the vial’s behaviour different from the body’s.
The delivery is not natural either
The second inversion is the route. α-MSH is made where it acts — in the skin, in specific brain circuits, in tiny quantities, at the moment it is needed. Melanotan II arrives by injection or nasal spray into the general circulation, and from there it goes wherever blood goes: everywhere, the brain included, more or less at once.
So a signal the body runs as a series of local, disposable whispers becomes, from the vial, a body-wide broadcast that outlasts the natural signal many times over. Every melanocortin receptor in the body — all five families of them (one hormone, five receptors) — receives the same message simultaneously. The skin answers with pigment. The brain answers with nausea, suppressed appetite, and arousal. None of that is the body doing what it naturally does. It is the body doing what it has no choice but to do when a durable, non-selective agonist reaches every receptor it owns.
The pharmacokinetic file covers the mechanics of this in detail. The point here is the vocabulary: the word “natural” describes the hormone. It does not describe the analog, the dose form, the route, or the duration. Four out of five things that determine what the molecule does in a body are engineered, and the market sells you the fifth.
“Natural” has never meant safe
Even setting the pharmacology aside, the inference was always invalid. Nature is not a safety certification. Arsenic, botulinum toxin, and hemlock are all natural, and the body is fully capable of manufacturing its own poisons — the UV-driven pigment response itself is a damage repair, not a gift.
What the claim actually borrows is a feeling: the warmth of supplements, of bio-identical hormone language, of things sold in wellness aisles rather than prescribed. Melanotan II fits none of those categories. It is a synthetic cyclic peptide, approved nowhere, for anything, sold by vendors who cannot say what it is in them. The TGA’s January 2025 warning is explicit that there is no way of knowing what is in these products no matter what the label says — and Australia has since made possession itself a Schedule 9 offence.
There is also a quieter contradiction in how the market deploys the word. In the UK, nasal Melanotan sprays are sold precisely as cosmetics — because claiming they are medicines would put them inside the regulator’s reach. A product cannot be “your body’s own natural hormone” on the marketing page and a cosmetic trinket on the legal one. It is whichever word the seller needs at the moment.
What the fallacy is really for
The naturalness claim survives because it is aimed at the one fear the market cannot talk about: that this is a drug. Calling it a hormone the body already makes converts a pharmacology problem into a supplement conversation, where standards are lower and questions feel optional.
The honest version of the sentence would be: the body has a pigment signal, and this molecule is built to hijack it. That is true, and it is also why the original developers abandoned Melanotan II as a lifestyle drug while the effects were split into the three narrow, tested medicines that followed. The body’s whisper was never the problem. The broadcast is.
A legitimate photoprotective agonist, if one ever arrives, will arrive the way afamelanotide did — selective, metered, controlled in place and time (the middle-ground agonist already exists). It will work with the body’s design instead of overruling it. Until then, the word “natural” on a Melanotan listing is not a description of the product. It is a description of the feeling the seller wants you to have while buying it.